Ignite Creation Date:
2025-12-25 @ 12:20 AM
Ignite Modification Date:
2026-01-04 @ 5:58 AM
Study NCT ID:
NCT03326258
Status:
WITHDRAWN
Last Update Posted:
2018-07-18
First Post:
2017-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-30
First Submit QC Date:
None
Study First Post Date:
2017-10-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-17
Last Update Post Date:
2018-07-18
Last Update Post Date Type:
ACTUAL